Prolonged cardiac repolarization after tacrolimus and haloperidol administration in the critically ill patient

被引:15
作者
Akers, WS
Flynn, JD
Davis, GA
Green, AE
Winstead, PS
Strobel, G
机构
[1] Univ Kentucky, Coll Pharm, Div Pharm Practice & Sci, Lexington, KY 40536 USA
[2] Univ Kentucky, Med Ctr, Dept Pharm Serv, Lexington, KY USA
[3] Univ Kentucky, Coll Med, Div Cardiol, Lexington, KY USA
来源
PHARMACOTHERAPY | 2004年 / 24卷 / 03期
关键词
QT interval; QT prolongation; cardiac repolarization; torsade de pointes; tacrolimus; haloperidol;
D O I
10.1592/phco.24.4.404.33172
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A 42-year-old woman who underwent single lung transplantation who received tacrolimus and a 58-year-old woman with pneumonia and multiple comorbidities who received haloperidol both experienced drug-induced prolongation of cardiac repolarization. The second woman also developed torsade de pointes. Critically ill patients are particularly susceptible to developing torsade de pointes due to various comorbidities, electrolyte disturbances, and receipt of numerous drugs. These two case reports illustrate the increased risk for drug-induced cardiotoxicity in the critically ill patient. They also indicate the need for current knowledge derived from basic research and retrospective case reports on drug-induced torsade de pointes to be integrated into the existing body of knowledge. Guidelines can then be developed to help prospectively reduce the frequency of adverse effects in intensive care patients. Research is necessary regarding identification of high-risk patients before drugs are administered, and clarification of the proper role of therapeutic QT monitoring in clinical practice.
引用
收藏
页码:404 / 408
页数:5
相关论文
共 11 条
[1]   The QT interval [J].
Bednar, MM ;
Harrigan, EP ;
Anziano, RJ ;
Camm, AJ ;
Ruskin, JN .
PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 43 (05) :1-45
[2]   Clinical relevance and management of drug-related QT interval prolongation [J].
Crouch, MA ;
Limon, L ;
Cassano, AT .
PHARMACOTHERAPY, 2003, 23 (07) :881-908
[3]   The assessment of potential for QT interval prolongation with new pharmaceuticals Impact on drug development [J].
Gralinski, MR .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 43 (02) :91-99
[4]   QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration - A case report [J].
Hodak, SP ;
Moubarak, JB ;
Rodriguez, I ;
Gelfand, MC ;
Alijani, MR ;
Tracy, CM .
TRANSPLANTATION, 1998, 66 (04) :535-537
[5]   QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF FK506 [J].
JOHNSON, MC ;
SO, S ;
MARSH, JW ;
MURPHY, AM .
TRANSPLANTATION, 1992, 53 (04) :929-930
[6]   Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: Pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect [J].
Minematsu, T ;
Ohtani, H ;
Yamada, Y ;
Sawada, Y ;
Sato, H ;
Iga, T .
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2001, 28 (06) :533-554
[7]   A common polymorphism associated with antibiotic-induced cardiac arrhythmia [J].
Sesti, F ;
Abbott, GW ;
Wei, J ;
Murray, KT ;
Saksena, S ;
Schwartz, PJ ;
Priori, SG ;
Roden, DM ;
George, AL ;
Goldstein, SAN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10613-10618
[8]   Torsades de pointes associated with intravenous haloperidol in critically ill patients [J].
Sharma, ND ;
Rosman, HS ;
Padhi, ID ;
Tisdale, JE .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (02) :238-240
[9]   The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes [J].
Suessbrich, H ;
Schonherr, R ;
Heinemann, SH ;
Attali, B ;
Lang, F ;
Busch, AE .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (05) :968-974
[10]   The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: Comparison with QT interval prolongation for assessment of risk of Torsades de Pointes [J].
Tisdale, JE ;
Rasty, S ;
Padhi, ID ;
Sharma, ND ;
Rosman, H .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (12) :1310-1318